SAN DIEGO, April 1, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced positive topline data from a Phase 1 clinical study evaluating controlled-release delivery profiles ...
1 The Condensed Consolidated Balance Sheet Data has been derived from the audited financial statements as of that date. View original content to download multimedia ...
SAN FRANCISCO, Feb. 10, 2026 /PRNewswire/ -- Arena today announced the launch of its Academic Partnerships Program, a new initiative aimed at advancing research in AI evaluation, rankings, and ...
PARK CITY, Utah--(BUSINESS WIRE)--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the third quarter ended September 30, 2021. “During ...
PARK CITY, Utah--(BUSINESS WIRE)--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the second quarter ended June 30, 2021. “With today’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results